Ahmadvangsgaard8155

We present two important trends in the reactivity of the titanium complex [MeNacNacTi(Cl)η2-P(SiMe3)-PtBu2] (MeNacNac- = [Ar]NC(Me)CHC(Me)N[Ar]; Ar = 2,6-iPr2Ph) with nucleophilic reagents RLi (R = Ph2P, tBuO, (Me3Si)2N, and tBu2N) depending on the reaction medium. Reaction in nonpolar solvent (toluene) leads to three main products via an autoredox process and nucleophilic substitution at the Ti-atom to afford the Ti(IV) complex [MeNacNacTi(R)η2-P-PtBu2] (1 for R = PPh2), via the elimination of Me3SiR to afford Ti(III) complex [MeNacNacTi(Cl)η2-P-PtBu2]-[Li(12-crown-4)2]+ (2), and via 2e- reduction process to afford new ionic complex [ArNC(Me)CHC(Me)Ti═NArη1-P(SiMe3)-PtBu2]-[Li(12-crown-4)2]+ (3). Quite differently, the complex [MeNacNacTi(Cl)η2-P(SiMe3)-PtBu2] reacts with Ph2PLi in THF, unexpectedly yielding two new, four-coordinate Ti(IV) imido complexes 4a [ArNC(Me)═CHC(H)(Me)-P(PtBu2)Ti═NAr(Cl)]-[Li(12-crown-4)2]+·(toluene)2 and 4b [ArNC(CH2)CH═C(Me)-P(PtBu2)Ti═NAr(Cl)]-[Li(12-crown-4)2]+·(Et2O). Complex 2 dissolved in THF converts to 4a and 4b. 1, 2, 3, 4a, and 4b were characterized by X-ray diffraction. 1, 4a, and 4b were also fully characterized by multinuclear NMR spectroscopy.Neutral, mononuclear aluminum and gallium radicals, stabilized by cyclic (alkyl)(amino)carbene (cAAC), were synthesized. LMCl2 upon reduction with KC8 in the presence of cAAC afforded the radicals LMCl(cAAC), where L = PhC(N t Bu)2 and M = Al (1), Ga (2). The radicals were characterized by X-ray crystallography, electron paramagnetic resonance (EPR) spectroscopy, and mass spectrometry. EPR, SQUID measurement, and computational calculations confirmed paramagnetism of the radicals with unpaired spin mainly on cAAC.Platinum drugs are widely used in clinics to treat various types of cancer. However, a number of severe side effects induced by the nonspecific binding of platinum drugs to normal tissues limit their clinical use. The conversion of platinum(II) drugs into more inert platinum(IV) derivatives is a promising strategy to solve this problem. Some platinum(IV) prodrugs, such as carboplatin-based tetracarboxylatoplatinum(IV) prodrugs, are not easily reduced to active platinum(II) species, leading to low cytotoxicity in vitro. In this study, we report the design and synthesis of a carboplatin-based platinum(IV) prodrug functionalized with a boron dipyrromethene (bodipy) ligand at the axial position, and the ligand acts as a photoabsorber to photoactivate the platinum(IV) prodrug. This compound, designated as BODI-Pt, is highly stable in the dark but quickly activated under irradiation to release carboplatin and the axial ligands. A cytotoxic study reveals that BODI-Pt is effective under irradiation, with cytotoxicity 11 times higher than that in the dark and 39 times higher than that of carboplatin in MCF-7 cells. Moreover, BODI-Pt has been proven to kill cancer cells by binding to the genomic DNA, arresting the cell cycle at the G2/M phase, inducing oncosis, and generating ROS upon irradiation. In summary, we report a green-light-activatable and carboplatin-based Pt(IV) prodrug with improved cytotoxicity against cancer cells, and our strategy can be used as a promising way to effectively activate carboplatin-based platinum(IV) prodrugs.Tridentate aroyl hydrazones are effective metal chelators in biological settings, and their activity has been investigated extensively for medicinal applications in metal overload, cancer, and neurodegenerative diseases. The aroyl hydrazone motif is found in the recently reported prochelator (AH1-S)2, which has shown antiproliferative proapoptotic activity in mammalian cancer cell lines. Intracellular reduction of this disulfide prochelator leads to the formation of mercaptobenzaldehyde benzoylhydrazone chelator AH1 and to iron sequestration, which in turn impacts cell growth. Herein, we investigate the iron coordination chemistry of AH1 to determine the structural and spectroscopic properties of the iron complexes in the solid state and in solution. A neutral iron(III) complex of 21 ligand-to-metal stoichiometry was isolated and characterized fully to reveal two different binding modes for the tridentate AH1 ligand. Specifically, one ligand binds in the monoanionic keto form, whereas the other ligand coordinates as a dianionic enolate. Continuous-wave electron paramagnetic resonance experiments in frozen solutions indicated that this neutral complex is one of three low-spin iron(III) complexes observed depending on the pH of the solution. Electron spin echo envelope modulation (ESEEM) experiments allowed assignment of the three species to different protonation states of the coordinated ligands. Sepantronium Our ESEEM analysis provides a method to distinguish the coordination of aroyl hydrazones in the keto and enolate forms, which influences both the ligand field and overall charge of the complex. As such, this type of analysis could provide valuable information in a variety of studies of iron complexes of aroyl hydrazones, ranging from the investigation of spin-crossover behavior to tracking of their distribution in biological samples.The nitrogenase enzymes are responsible for all biological nitrogen reduction. How this is accomplished at the atomic level, however, has still not been established. The molybdenum-dependent nitrogenase has been extensively studied and is the most active catalyst for dinitrogen reduction of the nitrogenase enzymes. The vanadium-dependent form, on the other hand, displays different reactivity, being capable of CO and CO2 reduction to hydrocarbons. Only recently did a crystal structure of the VFe protein of vanadium nitrogenase become available, paving the way for detailed theoretical studies of the iron-vanadium cofactor (FeVco) within the protein matrix. The crystal structure revealed a bridging 4-atom ligand between two Fe atoms, proposed to be either a CO32- or NO3- ligand. Using a quantum mechanics/molecular mechanics model of the VFe protein, starting from the 1.35 Å crystal structure, we have systematically explored multiple computational models for FeVco, considering either a CO32- or NO3- ligand, three different redox states, and multiple broken-symmetry states.